Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Oncology Reports
|
September 6, 2005
Erythropoietic agents in anaemic patients with cancer: a retrospective observational survey of epoetin alpha, epoetin beta and darbepoetin alpha use in routine clinical practice
Eric Pujade-Lauraine, Alain J Richard, Claudine Sapède, et al.
Blood Purification
|
November 11, 2008
Healthcare resource utilization for anemia management: current practice with erythropoiesis-stimulating agents and the impact of converting to once-monthly C.E.R.A
Ulrich Saueressig, Jonathan T C Kwan, Erwin De Cock, et al.
Therapie
|
September 19, 2016
Progression-free survival, overall survival and quality of life: What is their medicoeconomic importance in oncology?
Mira Pavlovic, Jérôme Garnier, Isabelle Durand-Zaleski, et al.
Therapie
|
August 29, 2013
Pharmacoepidemiology studies: what levels of evidence and how can they be reached?
Maryse Lapeyre-Mestre, Claudine Sapède, Nicholas Moore, et al.
Therapie
|
July 10, 2016
[Not Available]
Maryse Lapeyre-Mestre, Claudine Sapède, Nicholas Moore, et al.
Therapie
|
September 18, 2014
Medico-economic evaluation of healthcare products. Methodology for defining a significant impact on French health insurance costs and selection of benchmarks for interpreting results
Benoît Dervaux, Eric Baseilhac, Jean-Yves Fagon, et al.
Therapie
|
July 10, 2016
[Not Available]
Benoît Dervaux, Eric Baseilhac, Jean-Yves Fagon, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Oncology Reports
|
September 6, 2005
Erythropoietic agents in anaemic patients with cancer: a retrospective observational survey of epoetin alpha, epoetin beta and darbepoetin alpha use in routine clinical practice
Eric Pujade-Lauraine, Alain J Richard, Claudine Sapède, et al.
Blood Purification
|
November 11, 2008
Healthcare resource utilization for anemia management: current practice with erythropoiesis-stimulating agents and the impact of converting to once-monthly C.E.R.A
Ulrich Saueressig, Jonathan T C Kwan, Erwin De Cock, et al.
Therapie
|
September 19, 2016
Progression-free survival, overall survival and quality of life: What is their medicoeconomic importance in oncology?
Mira Pavlovic, Jérôme Garnier, Isabelle Durand-Zaleski, et al.
Therapie
|
August 29, 2013
Pharmacoepidemiology studies: what levels of evidence and how can they be reached?
Maryse Lapeyre-Mestre, Claudine Sapède, Nicholas Moore, et al.
Therapie
|
July 10, 2016
[Not Available]
Maryse Lapeyre-Mestre, Claudine Sapède, Nicholas Moore, et al.
Therapie
|
September 18, 2014
Medico-economic evaluation of healthcare products. Methodology for defining a significant impact on French health insurance costs and selection of benchmarks for interpreting results
Benoît Dervaux, Eric Baseilhac, Jean-Yves Fagon, et al.
Therapie
|
July 10, 2016
[Not Available]
Benoît Dervaux, Eric Baseilhac, Jean-Yves Fagon, et al.
Page
of 1